A Study of the Efficacy and Safety of Ranquilon Tablets in Patients With Anxiety in Neurasthenia and Adjustment Disorders
Clinical trial NCT05586789 · COMPLETED
Trial details
- NCT number
- NCT05586789
- Sponsor
- Valenta Pharm JSC
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-10-12
- Primary completion
- 2022-11-22
- Enrollment
- 220
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.